A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

Saint Vincents Hosp, New York

Howard Univ, Washington D.C.

GCRC, Washington D.C.

Wake Med CRI, Raleigh

Insite Clinical Trials, Decatur

Phillip Branchman, Atlanta

Central Florida Research Initiative, Maitland

Rosemont Health Care Ctr, Orlando

Community CRI of South Florida, Coral Gables

Deering Hosp, Miami

Ctr for Quality Care, Tampa

Mem Hosp of Tampa, Tampa

Wayne State Univ, Detroit

Regions Hosp, Saint Paul

Hennepin County Med Ctr, Minneapolis

Oak Park Hosp, Oak Park

Washington Univ School of Medicine, St Louis

New Orleans Pharmaceutical Research, Kenner

Joseph Gathe, Houston

GCRC - VA Hosp, San Antonio

South Texas Veterans Health Care System, San Antonio

Hill Top Research Ltd, Scottsdale

Phoenix Living Ctr, Scottsdale

Lynn House Hospice, West Hollywood

AIDS Research Alliance, West Hollywood

UCLA Care Ctr, Los Angeles

San Francisco Gen Hosp, San Francisco

AIDS Research Ctr / Dept of Veterans Affairs, Palo Alto

Bailey Boushay House, Seattle

Rosehedge House, Seattle

Brookdale Univ Hosp and Med Ctr, Brooklyn

Johns Hopkins Hosp, Baltimore

Indiana Univ Med Ctr, Indianapolis

New England Med Ctr, Boston

Hosp Regional de Ponce, Ponce

Clinical Research Puerto Rico Inc, San Juan